Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy
Background: Limited data reporting real-world prevalence of integrase strand transfer inhibitor resistance (INSTI-R) in the USA are available because their recommendation as first-line treatment in 2017. Reported national surveillance data in the USA estimated INSTI-R to be 6.3% as of 2018. This art...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
BioExcel Publishing Ltd,
2024-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|